A clinicopathological retrospective study of 131 patients with primary bone lymphoma: A population-based study of successively treated cohorts from the British Columbia Cancer Agency

Annals of Oncology

Volumn 18, Issue 1, 2007, Pages 129-135

  Ramadan, K M ^a   Shenkier, T ^a   Sehn, L H ^a   Gascoyne, R D ^a   Connors, J M ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Bone; Lymphoma; Presentation; Treatment

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER STAGING; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; HUMAN; LARGE CELL LYMPHOMA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PATHOLOGIC FRACTURE; PRIMARY BONE LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SPINAL CORD COMPRESSION; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; BRITISH COLUMBIA; COHORT STUDIES; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MEDICAL RECORDS; MIDDLE AGED; PREDNISONE; PROGNOSIS; RADIOTHERAPY; RETROSPECTIVE STUDIES; VINCRISTINE;

EID: 33846554856     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdl329     Document Type: Article

References (20)

1. Dahlin DC, UK Bone Tumors, 4th edition. Springfield, IL: Thomas 1986; 208-226.
2. Limb D, Dreghorn C, Murphy JK, Mannion R. Primary lymphoma of bone. Int Orthop 1994; 18: 180.
3. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1972; 29: 252.
4. Rosenberg S, Diamond HD, Jaslowitz B, Craver LF. Lymphosarcoma: A review of 1269 cases. Medicine (Baltimore) 1961; 40: 31.
5. Dubey P, Ha CS, Besa PC et al. Localized primary malignant lymphoma of bone. Int J Radiat Oncol Biol Phys 1997; 37: 1087-1093.
6. Heyning FH, Hogendoom PC, Kramer MHH et al. Primary non-Hodgkin's lymphoma of bone: A clinicopathological investigation of 60 cases. Leukemia 1999; 13: 2094-2098.
7. Stein ME, Kuten A, Gez E et al. Primary lymphoma of bone-A retrospective study. Oncology 2003; 64: 322-327.
8. Mulligan ME, McRae G, Murphey MD. Imaging features of primary lymphoma of bone. AJR Am J Roentgenol 1999; 173: 1691-1697.
9. Pettit CK, Zuckerberg L, Gray MH et al. Primary lymphoma of bone: A B-cell neoplasm with a high frequency of multilobated cells. Am J Surg Pathol 1990; 14: 329-334.
10. Baar J, Burkes RL, Bell R et al. Primary non-Hodgkin's lymphoma of bone: a clinicopathological study. Cancer 1994; 73: 1194-1199.
11. Jaffe ES, Harris NL, Stein H, Vardiman JW. World Health Organization Classification of Tumors: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC 2001.
12. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. New Engl J Med 1993; 329: 987-994.
13. Armitage JO, Corder MP, Leimert JT et al. Advanced diffuse histiocytic lymphoma treated with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) without maintenance therapy. Cancer Treatment Rep 1980; 64: 649-654.
14. Hoskins PJ, Le N, Gascoyne RD et al. Advanced diffuse large-cell lymphoma treated with 12 week combination chemotherapy: Natural history of relapse after initial complete response and prognostic variables defining outcome after relapse. Ann Oncol 1997; 8: 1125-1132.
15. Coiffier B, Lepage E, Herbrecht R et al. Mabthera (rituximab) plus CHOP is superior to CHOP alone in elderly patients with diffuse large B-cell lymphoma (DLCL): Interim results of a randomized GELA trial. Blood 2000; 96: 223a (Abstr 950).
16. Coiffier B, Lepage E, Briere J et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. New Engl J Med 2002; 346: 235-242.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
18. Parker F, Jackson H. Primary reticulum cell sarcoma of bone. Surg Gynecol Obstet 1939; 68: 45.
19. Sehn LH, Donaldson J, Chhanabhai M et al. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol 2005; 23: 5027-5033.
20. Fairbanks RK, Bonner JA, Inwards CY et al. Treatment of stage IE primary lymphoma of bone. Int J Radiat Oncol Biol Phys 1994; 28 (2): 363-372.